MediPharm Labs Corp. (MEDIF)
MediPharm Labs Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Barrie, ON, CA. The stock last traded at $0.05, up 2.00% on the session, giving a market capitalisation of $21.7M. On trailing twelve-month figures it carries a trailing P/E of -6.03, a net margin of -12.0%. Its beta of 0.99 implies it has historically moved less than the broad market.
MediPharm Labs Corp. operates as a pharmaceutical firm specializing in the manufacturing and distribution of pharmaceutical-grade cannabis oils, concentrates, and advanced derivative products. The company's market presence spans Canada, Australia, Germany, and other international territories. Its comprehensive services encompass the formulation, processing, packaging, and distribution of sophisticated cannabinoid-based offerings. Additionally, MediPharm Labs provides GMP-compliant sourcing, packaging, and distribution services for cannabis flower. The organization was established in 2015 and is headquartered in Barrie, Canada.
MediPharm Labs Corp. is most often compared with the following Healthcare names: